COMMUNIQUÉ DE PRESSE
News
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Viromed Medical AG: Revolutionary cold plasma therapy for the treatment of ventilator-associated pneumonia (VAP) shows 100% efficacy in an in vitro study with MRSA and human lung cells (alveoli)
Viromed Medical AG announces groundbreaking results with cold plasma therapy for ventilator-associated pneumonia (VAP) in an in vitro study. Findings show 100% efficacy against MRSA bacteria without lung cell damage -
-
-
COMMUNIQUÉ DE PRESSE
Exclusive contract for ViroCAP® My Plasma with Landsberg First Class Aesthetic opens up Viromed's entry into the European cosmetics market
Viromed Medical AG partners with Landsberg First Class Aesthetic to introduce ViroCAP® My Plasma into the European cosmetics market, enhancing aesthetic treatments with cold plasma technology
